×

Select Your Country

International
English
Go back
Manipal Hospitals Baner

Dr. Rajendra Pol

Consultant - Heamatology

Baner

Qualification

MBBS MD MRCP FRCPATH BSBMT(UK)

Get a second opinion
Video consultation

Fellowship & Membership

  • British Society of Heamatology UK.
  • Member of Royal College of Pathologists UK.

Field of Expertise

  • Haematology

Languages Spoken

  • English
  • Hindi
  • Marathi
  • Gujrati

Talks & Publications

  • Bone marrow fibrosis is not a predictor of overall survival in patients with multiple myeloma. R Pol, S Paneesha, N Chachlani, H Freeman, P Roberts, G Pratt, P Rose and A Borg. British Journal of Haematology 2006, 108, 133, (Suppl. 1), 1-121 (Abstract).
  • Dexamethasone, Ifosfamide, Carboplatin and Etoposide (DICarE) with/out Rituximab is an effective regimen for elderly patients with high-grade lymphoma and poor cardiac function. S Paneesha, C Connor, R Pol, N Evans, N Chachlani, P Rose and A Borg. British Journal of Haematology 2006, 108, 133, (Suppl. 1), 1-121 (Abstract).
  • Bone Marrow Fibrosis is a Negative Predictor for Osteolytic Lesions in Patients with Myeloma. S Paneesha, Raj Pol, N Chachlani, Guy Pratt, Peter Rose and Anton Borg. ‘American Society of Haematology’ Dec 2006. ‘British Journal of Haematology 2007’.
  • Image: ‘All that glitters is not gold’ (Thrombocytosis as a manifestation of renal cell carcinoma). S Paneesha, R Pol. N Chachlani, M Hughes, K Chen, P Rose and A Borg. Bloodmed 2006.
  • http://www.bloodmed.com/education/case1.asp?id=2065. The use of a faecal management device in gastrointestinal graft-versus-host disease.
  • S. Liebersbach, A. Wood, N. Davis, R. Pol, R. Mazumdar, G. Cook, M. Gilleece (Leeds, UK), 36th Annual Meeting of the European Group for Blood and Marrow Transplantation, Vienna, Austria, March 2010.
  • Image - Daunorubicin-induced Hyperpigmentation, published in British Journal of Haematology in Aug 2010. Raj Pol, Andrew Wright, Anita Hill.
  • Image – A man with anaemia and a change in personality, Blood, March 2014. Raj Pol, Martin Howard.
  • A Single centre experience in severe Veno-Occlusive Disease and Early Treatment with Defibrotide. Raj R. Pol, Nigel Russell, Emma Das-Gupta, Lynne Watson, Lisa Rachael, Jenny Byrne. Bone Marrow Transplantation advance online publication, 25 April 2016; doi:10.1038/bmt.2016.99. Also EBMT oral presentation in 2016.
  • Effective Treatment of Steroid and Therapy-R.

Fellowship & Membership

  • British Society of Heamatology UK.
  • Member of Royal College of Pathologists UK.

Field of Expertise

  • Haematology

Languages Spoken

  • English
  • Hindi
  • Marathi
  • Gujrati

Talks & Publications

  • Bone marrow fibrosis is not a predictor of overall survival in patients with multiple myeloma. R Pol, S Paneesha, N Chachlani, H Freeman, P Roberts, G Pratt, P Rose and A Borg. British Journal of Haematology 2006, 108, 133, (Suppl. 1), 1-121 (Abstract).
  • Dexamethasone, Ifosfamide, Carboplatin and Etoposide (DICarE) with/out Rituximab is an effective regimen for elderly patients with high-grade lymphoma and poor cardiac function. S Paneesha, C Connor, R Pol, N Evans, N Chachlani, P Rose and A Borg. British Journal of Haematology 2006, 108, 133, (Suppl. 1), 1-121 (Abstract).
  • Bone Marrow Fibrosis is a Negative Predictor for Osteolytic Lesions in Patients with Myeloma. S Paneesha, Raj Pol, N Chachlani, Guy Pratt, Peter Rose and Anton Borg. ‘American Society of Haematology’ Dec 2006. ‘British Journal of Haematology 2007’.
  • Image: ‘All that glitters is not gold’ (Thrombocytosis as a manifestation of renal cell carcinoma). S Paneesha, R Pol. N Chachlani, M Hughes, K Chen, P Rose and A Borg. Bloodmed 2006.
  • http://www.bloodmed.com/education/case1.asp?id=2065. The use of a faecal management device in gastrointestinal graft-versus-host disease.
  • S. Liebersbach, A. Wood, N. Davis, R. Pol, R. Mazumdar, G. Cook, M. Gilleece (Leeds, UK), 36th Annual Meeting of the European Group for Blood and Marrow Transplantation, Vienna, Austria, March 2010.
  • Image - Daunorubicin-induced Hyperpigmentation, published in British Journal of Haematology in Aug 2010. Raj Pol, Andrew Wright, Anita Hill.
  • Image – A man with anaemia and a change in personality, Blood, March 2014. Raj Pol, Martin Howard.
  • A Single centre experience in severe Veno-Occlusive Disease and Early Treatment with Defibrotide. Raj R. Pol, Nigel Russell, Emma Das-Gupta, Lynne Watson, Lisa Rachael, Jenny Byrne. Bone Marrow Transplantation advance online publication, 25 April 2016; doi:10.1038/bmt.2016.99. Also EBMT oral presentation in 2016.
  • Effective Treatment of Steroid and Therapy-R.

Field of Expertise

  • Haematology

Fellowship & Membership

  • British Society of Heamatology UK.
  • Member of Royal College of Pathologists UK.

Languages Spoken

  • English
  • Hindi
  • Marathi
  • Gujrati

Talks & Publications

  • Bone marrow fibrosis is not a predictor of overall survival in patients with multiple myeloma. R Pol, S Paneesha, N Chachlani, H Freeman, P Roberts, G Pratt, P Rose and A Borg. British Journal of Haematology 2006, 108, 133, (Suppl. 1), 1-121 (Abstract).
  • Dexamethasone, Ifosfamide, Carboplatin and Etoposide (DICarE) with/out Rituximab is an effective regimen for elderly patients with high-grade lymphoma and poor cardiac function. S Paneesha, C Connor, R Pol, N Evans, N Chachlani, P Rose and A Borg. British Journal of Haematology 2006, 108, 133, (Suppl. 1), 1-121 (Abstract).
  • Bone Marrow Fibrosis is a Negative Predictor for Osteolytic Lesions in Patients with Myeloma. S Paneesha, Raj Pol, N Chachlani, Guy Pratt, Peter Rose and Anton Borg. ‘American Society of Haematology’ Dec 2006. ‘British Journal of Haematology 2007’.
  • Image: ‘All that glitters is not gold’ (Thrombocytosis as a manifestation of renal cell carcinoma). S Paneesha, R Pol. N Chachlani, M Hughes, K Chen, P Rose and A Borg. Bloodmed 2006.
  • http://www.bloodmed.com/education/case1.asp?id=2065. The use of a faecal management device in gastrointestinal graft-versus-host disease.
  • S. Liebersbach, A. Wood, N. Davis, R. Pol, R. Mazumdar, G. Cook, M. Gilleece (Leeds, UK), 36th Annual Meeting of the European Group for Blood and Marrow Transplantation, Vienna, Austria, March 2010.
  • Image - Daunorubicin-induced Hyperpigmentation, published in British Journal of Haematology in Aug 2010. Raj Pol, Andrew Wright, Anita Hill.
  • Image – A man with anaemia and a change in personality, Blood, March 2014. Raj Pol, Martin Howard.
  • A Single centre experience in severe Veno-Occlusive Disease and Early Treatment with Defibrotide. Raj R. Pol, Nigel Russell, Emma Das-Gupta, Lynne Watson, Lisa Rachael, Jenny Byrne. Bone Marrow Transplantation advance online publication, 25 April 2016; doi:10.1038/bmt.2016.99. Also EBMT oral presentation in 2016.
  • Effective Treatment of Steroid and Therapy-R.

Languages Spoken

  • English
  • Hindi
  • Marathi
  • Gujrati

Fellowship & Membership

  • British Society of Heamatology UK.
  • Member of Royal College of Pathologists UK.

Field of Expertise

  • Haematology

Talks & Publications

  • Bone marrow fibrosis is not a predictor of overall survival in patients with multiple myeloma. R Pol, S Paneesha, N Chachlani, H Freeman, P Roberts, G Pratt, P Rose and A Borg. British Journal of Haematology 2006, 108, 133, (Suppl. 1), 1-121 (Abstract).
  • Dexamethasone, Ifosfamide, Carboplatin and Etoposide (DICarE) with/out Rituximab is an effective regimen for elderly patients with high-grade lymphoma and poor cardiac function. S Paneesha, C Connor, R Pol, N Evans, N Chachlani, P Rose and A Borg. British Journal of Haematology 2006, 108, 133, (Suppl. 1), 1-121 (Abstract).
  • Bone Marrow Fibrosis is a Negative Predictor for Osteolytic Lesions in Patients with Myeloma. S Paneesha, Raj Pol, N Chachlani, Guy Pratt, Peter Rose and Anton Borg. ‘American Society of Haematology’ Dec 2006. ‘British Journal of Haematology 2007’.
  • Image: ‘All that glitters is not gold’ (Thrombocytosis as a manifestation of renal cell carcinoma). S Paneesha, R Pol. N Chachlani, M Hughes, K Chen, P Rose and A Borg. Bloodmed 2006.
  • http://www.bloodmed.com/education/case1.asp?id=2065. The use of a faecal management device in gastrointestinal graft-versus-host disease.
  • S. Liebersbach, A. Wood, N. Davis, R. Pol, R. Mazumdar, G. Cook, M. Gilleece (Leeds, UK), 36th Annual Meeting of the European Group for Blood and Marrow Transplantation, Vienna, Austria, March 2010.
  • Image - Daunorubicin-induced Hyperpigmentation, published in British Journal of Haematology in Aug 2010. Raj Pol, Andrew Wright, Anita Hill.
  • Image – A man with anaemia and a change in personality, Blood, March 2014. Raj Pol, Martin Howard.
  • A Single centre experience in severe Veno-Occlusive Disease and Early Treatment with Defibrotide. Raj R. Pol, Nigel Russell, Emma Das-Gupta, Lynne Watson, Lisa Rachael, Jenny Byrne. Bone Marrow Transplantation advance online publication, 25 April 2016; doi:10.1038/bmt.2016.99. Also EBMT oral presentation in 2016.
  • Effective Treatment of Steroid and Therapy-R.

Talks & Publications

  • Bone marrow fibrosis is not a predictor of overall survival in patients with multiple myeloma. R Pol, S Paneesha, N Chachlani, H Freeman, P Roberts, G Pratt, P Rose and A Borg. British Journal of Haematology 2006, 108, 133, (Suppl. 1), 1-121 (Abstract).
  • Dexamethasone, Ifosfamide, Carboplatin and Etoposide (DICarE) with/out Rituximab is an effective regimen for elderly patients with high-grade lymphoma and poor cardiac function. S Paneesha, C Connor, R Pol, N Evans, N Chachlani, P Rose and A Borg. British Journal of Haematology 2006, 108, 133, (Suppl. 1), 1-121 (Abstract).
  • Bone Marrow Fibrosis is a Negative Predictor for Osteolytic Lesions in Patients with Myeloma. S Paneesha, Raj Pol, N Chachlani, Guy Pratt, Peter Rose and Anton Borg. ‘American Society of Haematology’ Dec 2006. ‘British Journal of Haematology 2007’.
  • Image: ‘All that glitters is not gold’ (Thrombocytosis as a manifestation of renal cell carcinoma). S Paneesha, R Pol. N Chachlani, M Hughes, K Chen, P Rose and A Borg. Bloodmed 2006.
  • http://www.bloodmed.com/education/case1.asp?id=2065. The use of a faecal management device in gastrointestinal graft-versus-host disease.
  • S. Liebersbach, A. Wood, N. Davis, R. Pol, R. Mazumdar, G. Cook, M. Gilleece (Leeds, UK), 36th Annual Meeting of the European Group for Blood and Marrow Transplantation, Vienna, Austria, March 2010.
  • Image - Daunorubicin-induced Hyperpigmentation, published in British Journal of Haematology in Aug 2010. Raj Pol, Andrew Wright, Anita Hill.
  • Image – A man with anaemia and a change in personality, Blood, March 2014. Raj Pol, Martin Howard.
  • A Single centre experience in severe Veno-Occlusive Disease and Early Treatment with Defibrotide. Raj R. Pol, Nigel Russell, Emma Das-Gupta, Lynne Watson, Lisa Rachael, Jenny Byrne. Bone Marrow Transplantation advance online publication, 25 April 2016; doi:10.1038/bmt.2016.99. Also EBMT oral presentation in 2016.
  • Effective Treatment of Steroid and Therapy-R.

Fellowship & Membership

  • British Society of Heamatology UK.
  • Member of Royal College of Pathologists UK.

Field of Expertise

  • Haematology

Languages Spoken

  • English
  • Hindi
  • Marathi
  • Gujrati

Talks & Publications

  • Bone marrow fibrosis is not a predictor of overall survival in patients with multiple myeloma. R Pol, S Paneesha, N Chachlani, H Freeman, P Roberts, G Pratt, P Rose and A Borg. British Journal of Haematology 2006, 108, 133, (Suppl. 1), 1-121 (Abstract).
  • Dexamethasone, Ifosfamide, Carboplatin and Etoposide (DICarE) with/out Rituximab is an effective regimen for elderly patients with high-grade lymphoma and poor cardiac function. S Paneesha, C Connor, R Pol, N Evans, N Chachlani, P Rose and A Borg. British Journal of Haematology 2006, 108, 133, (Suppl. 1), 1-121 (Abstract).
  • Bone Marrow Fibrosis is a Negative Predictor for Osteolytic Lesions in Patients with Myeloma. S Paneesha, Raj Pol, N Chachlani, Guy Pratt, Peter Rose and Anton Borg. ‘American Society of Haematology’ Dec 2006. ‘British Journal of Haematology 2007’.
  • Image: ‘All that glitters is not gold’ (Thrombocytosis as a manifestation of renal cell carcinoma). S Paneesha, R Pol. N Chachlani, M Hughes, K Chen, P Rose and A Borg. Bloodmed 2006.
  • http://www.bloodmed.com/education/case1.asp?id=2065. The use of a faecal management device in gastrointestinal graft-versus-host disease.
  • S. Liebersbach, A. Wood, N. Davis, R. Pol, R. Mazumdar, G. Cook, M. Gilleece (Leeds, UK), 36th Annual Meeting of the European Group for Blood and Marrow Transplantation, Vienna, Austria, March 2010.
  • Image - Daunorubicin-induced Hyperpigmentation, published in British Journal of Haematology in Aug 2010. Raj Pol, Andrew Wright, Anita Hill.
  • Image – A man with anaemia and a change in personality, Blood, March 2014. Raj Pol, Martin Howard.
  • A Single centre experience in severe Veno-Occlusive Disease and Early Treatment with Defibrotide. Raj R. Pol, Nigel Russell, Emma Das-Gupta, Lynne Watson, Lisa Rachael, Jenny Byrne. Bone Marrow Transplantation advance online publication, 25 April 2016; doi:10.1038/bmt.2016.99. Also EBMT oral presentation in 2016.
  • Effective Treatment of Steroid and Therapy-R.

Fellowship & Membership

  • British Society of Heamatology UK.
  • Member of Royal College of Pathologists UK.

Field of Expertise

  • Haematology

Languages Spoken

  • English
  • Hindi
  • Marathi
  • Gujrati